EYE is committed to the Immunization Agenda 2030.
Please see below statements from Dr Katherine O' Brien (Director - Immunization, Vaccines and Biologicals, WHO) and Dr Laurence Cibrelus (Lead, Global EYE Secretariat).
|
|
|
|
Sudanese authorities carried out an oral cholera and yellow fever vaccination campaign among Ethiopian refugees at Hamdayeet reception centre, Kassala State, from 23 to 26 March 2021
|
|
|
Sudan In March, Sudan began its vaccination campaigns to protect refugees from yellow fever (YF) and catch-up campaigns with children born or eligible after the completion of the past preventive mass vaccination campaigns (PMVCs). Both catch-up and refugee outreach activities in the camps in Gedarif and Kassala are now complete.
More detailed information about the Sudan campaign can be found in our web story. Click here. South Sudan South Sudan is proposing to engage in a pre-emptive activity using leftover vaccine from its 2020 response. In March last year, an outbreak occurred in Kajo Keji, a region bordering Uganda.
This pre-emptive campaign aims to target 57,443 people from the ages of 9 months to 60 years. The campaign is expected to be conducted in May, pending confirmation of funding and logistics. Democratic Republic of Congo (DRC) DRC’s PMVCs began on 27th April 2021 in Kisangani, Tshopo and are due to run through to the end of July this year. In total, the campaigns aim to target over 18 million people in eight provinces (Bas Uélé, Haut Uélé, Equateur, Mongala, Tshuapa, Nord Ubangi, Sud Ubangi and Tshopo). DRC also plans to complete additional activities later in the year, aiming to target approximately 15 million people. EYE will also be filming vaccination activities in DRC to be shared later in the year. This is to showcase the scope and breadth of activities and expertise required to protect people against yellow fever, and to illustrate how the EYE strategy works in practice. Read more in our web story. Click here for English. Click here for French. Nigeria Nigeria received its GAVI decision letter in March 2021 and preparations are underway for PMVCs to target more than 26 million people in the latter part of 2021. Uganda Uganda is expected to receive its GAVI decision letter by the end of May 2021, with preparations already underway for PMVCs. More details to follow as we have them.
|
|
|
|
We would like to periodically update you on vaccination activities since the inception of EYE in 2017. The diagram below shows the number of people who have been vaccinated through PMVCs and reactive campaigns (RCs) in African high-risk countries. In Africa, this amounts to 141 million people.
|
|
|
| No. of people vaccinated through PMVCs & RVCs in African high-risk countries |
|
|
| *Numbers are regularly updated and may evolve based on final reports for 2020. ICG supported RVCs are classified by year of approval. Data is sourced from the EYE vaccination tracking records. |
|
|
|
YF diagnostic training workshop, Nigeria
|
|
|
|
In March, the Nigeria Centre for Disease Control (NCDC) held a YF diagnostic training workshop. Please click here for more information and photos about the event.
On the topic of the workshop, Celestina Obiekea, the Laboratory Network Advisor for the Nigeria Centre for Disease Control (NCDC) said, "If we are to achieve the objectives of the EYE strategy, it is critical that laboratory capacity for quick and efficient diagnosis of suspect cases be improved. Part of the work we are doing in Nigeria is to make sure we have adequate number of laboratories with a highly skilled workforce. This training of laboratory personnel is a key step to ensuring that this objective is fulfilled.”
Professor Oyewale Tomori, Professor of Virology at Redeemer's University, Nigeria commented: “The successful completion of the laboratory training in Nigeria has created not just a conducive environment for real-time confirmation of yellow fever outbreak, but also an enabling environment for responding rapidly and effectively to controlling and eventual elimination of yellow fever disease in Nigeria, and ultimately in Africa.”
|
|
|
Mohammed Omer
Mohamed has been working with the UNICEF Ethiopia Country Office as a Health and Nutrition Specialist since 2014, serving as focal point for health emergencies, polio eradication and humanitarian health issues. From 2012 to 2014, he co-ordinated health and nutrition services for Dollo Ado refugee programme, and was acting Head of UNICEF sub-office in Dollo Ado, Somali region of Ethiopia. |
|
|
Health Specialist, UNICEF East and
Southern Africa Regional Office (ESARO) |
|
|
Prior to 2014, Mohamed served as a Health Specialist in UNICEF Nyala, South Darfur, and before joining UNICEF, he worked with UNFPA as a Senior Reproductive Health Field officer in Darfur. He has extensive experience of supporting primary healthcare services and co-ordinating health sector support to the Darfur crisis. These populations have been among the priority populations for YF vaccinations in Sudan.
Mohamed is part of the EYE programme management group, the vaccine delivery working group, and the Regional Implementation team in Africa. |
|
|
OpenWHO.org is a free, open-access learning platform for health emergencies. Learn from public health experts about topics including COVID-19, risk communication, Ebola, infection prevention and more.
You can enrol here on the Introduction to Yellow Fever course. The course is available in English and French. |
|
|
Deadline for Gavi application submission round 2: 4 May 2021
IRC meeting (indicative dates): 28 June–9 July 2021
Deadline for Gavi application submission round 3: 15 September 2021
IRC meeting (indicative dates): 8–19 Nov 2021
|
|
|
We would love to showcase the work you are doing on protecting people from yellow fever. To submit your news, stories, photos and videos, please email This email address is being protected from spambots. You need JavaScript enabled to view it. |
|
|
To subscribe to this newsletter, click here.
Follow us on social media. Click on the icons below.
|
|
|
|
|
|
|
